Clinical Trials Directory

Trials / Completed

CompletedNCT01486563

Hydroxyethyl Starch and Renal Function After Radical Prostatectomy

Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Regional Hospital Holstebro · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

Detailed description

Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far acute kidney injury has been diagnosed based on creatinine measurements, but new technology allows for earlier diagnosis using measurements of biomarkers in urine. The purpose of this project is to investigate HES's potential toxicity and effects on the circulation and kidneys using measurements of biomarkers specific for toxicity and for the sodium/water balance in the urine and by measurements of vasoactive hormones in the blood after administration of HES 130/0.4

Conditions

Interventions

TypeNameDescription
DRUGVoluven (Hydroxyethyl starch 130/0,4)7,5 ml/kg in the first hour and then 5 ml/kg
DRUGSodium Chloride 9 mg/ml7,5 ml/kg in the first hour and then 5 ml/kg

Timeline

Start date
2012-01-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-12-06
Last updated
2013-09-17

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01486563. Inclusion in this directory is not an endorsement.